Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Lays Out Near-Term Growth Plan

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific’s ongoing effort to reorganize and recharge its product pipeline and reduce manufacturing costs will restore higher revenue growth over the next few years, executives said during a Nov. 19 day-long investor presentation.
Advertisement

Related Content

Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q1 2011
New Products In Brief
New Products In Brief
Boston Scientific Buys Atritech For Watchman Stroke Prevention Device
Boston Scientific Buys Atritech For Watchman Stroke Prevention Device
Boston Sci Makes Its Play In Transcatheter Valves With Sadra Acquisition
Boston Sci Controls New Asthma Device Market With Acquisition
Boston Scientific Gains Expanded Indication For CRT-D Devices
With Restructuring, Ray Elliott Makes Boston Scientific His Own
With Restructuring, Ray Elliott Makes Boston Scientific His Own

Topics

Advertisement
UsernamePublicRestriction

Register

MT029624

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel